Merk H H - OmicsDI

Show results for

Unknown (53)
Proteomics (22)
Transcriptomics (15)
Genomics (2)

Organisms

Homo sapiens (23)
Mus musculus (6)
Saccharomyces cerevisiae (2)
Xenopus laevis (1)
Anthozoa (1)
Arabidopsis thaliana (1)
Bordetella pertussis Tohama I (1)
Calicophoron daubneyi (1)
Conus magus (1)
Haemonchus contortus (1)
Schizosaccharomyces pombe (1)
Stylophora pistillata (1)

Repository

pride (22)
biostudies-arrayexpress (16)
ENA (1)

Tissue

Cell culture (4)
Brain (2)
Blood serum (1)
Bone cell (1)
Breast epithelial cell (1)
Breast epithelium (1)
Embryonic stem cell (1)
Endothelial cell of umbilical vein (1)
Epithelial cell (1)
Frontal lobe (1)
HepG2 cell (1)
Liver (1)
Mesenchymal stem cell of the bone marrow (1)
Osteoblast (1)
Plant cell (1)
Stem cell (1)
Stomach (1)
T cell (1)

Disease

Acute leukemia (1)
Bone giant cell tumor (1)
Breast cancer (1)
Colon cancer (1)
Disease free (1)
Down syndrome (1)
Lung carcinoma (1)
Malignant neoplasm of ovary (1)
Osteosarcoma (1)
Sarcoma (1)
Stomach cancer (1)

Technology Type

Mass Spectrometry (22)
Shotgun proteomics (12)
Bottom-up proteomics (6)
Data-dependent acquisition (5)
Affinity purification coupled with mass spectrometry proteomics (3)
Top-down proteomics (2)
Gel-based experiment (1)

Instrument Platform

Illumina NovaSeq 6000 (3)
Illumina HiSeq 2000 (2)
NextSeq 500 (2)
Illumina HiSeq 2500 (1)
Illumina HiSeq 3000 (1)

Publication Date

2025 (6)
2023 (5)
2021 (4)
2020 (4)
2015 (3)
2014 (3)
2026 (3)
2024 (3)
2022 (2)
2006 (2)
2017 (1)
2009 (1)
2018 (1)

First Public Date

2025 (1)

Study type

Transcription profiling by array (6)
RNA-seq of coding RNA (3)
Cell line - High-throughput sequencing (2)
RNA-seq of non coding RNA (2)
Translation profiling (1)
ChIP-seq (1)
RNA-seq of total RNA (1)

Release Date

2022 (11)
2023 (7)
2025 (7)
2021 (6)
2017 (5)
2014 (5)
2015 (4)
2024 (4)
2019 (4)
2016 (4)
2006 (2)
2020 (2)
2011 (2)
2010 (2)
2009 (1)
2018 (1)
2013 (1)
2012 (1)

Lab affiliation

1 Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China. 2 Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. 3 State Key Laboratory Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China. (1)
Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine (1)
Austrian Centre of Industrial Biotechnology (ACIB), Petersgasse 14, 8010 Graz, Austria; Medical University of Graz, Institute of Pathology, Research Unit Functional Proteomics and Metabolic Pathways, Stiftingtalstrasse 24, 8010 Graz, Austria; Omics Center Graz, BioTechMed-Graz, Stiftingtalstrasse 24, 8010 Graz, Austria. (1)
Basic Immune System of Plants / Protein Mass Spectrometry Max Planck Institute for Plant Breeding Research Carl-von-Linne-Weg 10, 50829 Cologne, Germany (1)
Dalian Institute of Chemical Physics, CAS (1)
Department of Marine Biology, University of Haifa, Israel (1)
Dept. of Molecular and Cellular Biology, University of Geneva (1)
Division of Applied Functional Genomics, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), NCT Heidelberg, Germany (1)
Head of the Laboratory of the Molecular Biology of Stem Cells, Institute of Cytology of the Russian Academy of Science, St. Petersburg, Russia (1)
Huazhong agricultural university (1)
Institute for Molecular Bioscience - University of Queensland (1)
Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University, Edward Llwyd Z2.01. (1)
Institute of Biomedicine University of Turku Kiinamyllynkatu 10 FI-20520 TURKU Finland (1)
Molecular Medicine Partnership Unit (MMPU), Heidelberg University, Heidelberg, Germany Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany (1)
Proteomics Unit, Spanish National Cancer Research Centre (CNIO) Melchor Fernández Almagro 3. E28029 MADRID, SPAIN. Phone +34 912246900 ext 3112 (1)
QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia 4006 (1)
SULFAGIN group, Leibniz-Institut für Analytische Wissenschaften, ISAS .eV, Germany (1)
SULFAGING group, Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V. DORTMUND Germany (1)
Sulfaging group, Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V., Dortmund, Germany (1)
TOngji University (1)
University of Edinburgh (1)
professor (1)

Previous page
1 / 10
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 10
Next page

Sort by:

Relevance

Page size

Transcription profiling of human chromic myeloid leukemia (CML) patients treated second-line with imatinib after failure of an interferon-alpha based therapy to identify genes with predictive value for primary cytogenetic outcome to imatinib

Identification of genes in CML patients with predictive value for their primary cytogenetic outcome to imatinib. All samples analyzed were taken just before the start of imatinib treatment. Leukemic patients were treated second-line with imatinib after failure of an interferon-alpha based therapy (f...

ORGANISM(S): Homo sapiens

2006-05-31 | E-MEXP-433 | biostudies-arrayexpress

Feasibility of smart wristbands for continuous monitoring during pregnancy and one month after birth.

Not available

S-EPMC6337833 | biostudies-literature

Comparative Profiling and Chemogenomics Application of Chemical Tools for NR4A Nuclear Receptors.

Not available

S-EPMC12516683 | biostudies-literature

Quantifying the incidence and cost of acute gastrointestinal illness in Sweden, 2013-2014.

Not available

S-EPMC9150422 | biostudies-literature

Molecular tuning of farnesoid X receptor partial agonism.

Not available

S-EPMC6606567 | biostudies-literature

RNA-seq to investigate the effect of SA112 a novel PPAR ligand in HepG2 cells

This study evaluated the effects of a novel type of PPAR ligand on gene expression in HepG2 cells

ORGANISM(S): Homo sapiens

2023-03-01 | E-MTAB-12166 | biostudies-arrayexpress

Endogenous vitamin E metabolites mediate allosteric PPARγ activation with unprecedented co-regulatory interactions

Effects of the PPARgamma ligands pioglitazone and garcinoic acid on gene expression in HepG2 cells

ORGANISM(S): Homo sapiens

2021-04-16 | E-MTAB-10328 | biostudies-arrayexpress

Nurr1 modulation mediates neuroprotective effects of statins

Effects of Nurr1 silencing and treatment with Nurr1 ligand Simvastatin in presence or absence of LPS-stimulus on gene expression in human astrocytes (T98G).

ORGANISM(S): Homo sapiens

2021-10-01 | E-MTAB-10624 | biostudies-arrayexpress

The microbiome as a biosensor: functional profiles elucidate hidden stress in hosts.

Not available

S-EPMC7243336 | biostudies-literature

STAT6 expression in glioblastoma promotes invasive growth.

Not available

S-EPMC3118945 | biostudies-literature